glp-1 anesthesia guidelines 🔸 Should RAs be continued preprocedurally? 🔸 Who should stop a GLP-1 RA preoperatively? 🔸 Which patients should have their procedures postponed? Read: https://doi.org/10.1097/01.ASM.0001125664.22893.9f Glucagon-Like Peptide-1 Agonists and General

Does my current health history include any conditions that may affect GLP-1 eligibility or safety

Some older studies have evaluated NAD+ at high doses (1-2g daily) for conditions such as chronic schizophrenia, but no improvement was noted in these studies.3 This may be because NAD+ is expected to have poor oral bioavailability.12 For this reason, when trying to boost NAD+ levels using an oral route, precursors such as nicotinamide or nicotinamide mononucleotide are typically used instead of NAD+

For consumers, that pricing premium is not always supported by the strength of the public clinical evidence

Synovial sarcoma, arising as it does in an undifferentiated mesenchymal precursor, can rarely present as a primary skin neoplasm

This weight regain is not inevitable, and there are ways to combat it